‘Good’ cholesterol drug may help diabetics

A drug designed to improve levels of `good` cholesterol may also help control blood sugar in diabetics who are on cholesterol-lowering drugs.

Researchers stumbled on this finding while analysing data from a clinical trial on the drug torcetrapib. The development of this drug was halted five years ago.

Torcetrapib is a cholesterol ester transfer protein (CETP) inhibitor, a type of drug that increases levels of high-density lipoproteins (HDLs, or `good` cholesterol), Journal of the American Heart Association.

The study found that 6,661 people with type 2 diabetes – also known as `adult-onset` diabetes – showed improved blood sugar control when taking torcetrapib along with a statin medication that reduces low-density lipoproteins (LDLs or `bad` cholesterol).

Why you are at risk for diabetes

The inhibitor drugs may not only reduce the risk of heart attack and stroke, but may also improve the control of blood sugar in people with diabetes.

Read the full story here